Percheron Therapeutics Limited
PERCF
$0.0025
-$0.0165-86.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -79.94% | -84.14% | -15.92% | -13.06% | 10.87% |
| Total Depreciation and Amortization | -23.38% | -21.94% | -33.33% | -35.58% | -1.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 163.19% | 164.02% | 109.85% | 109.61% | -101.85% |
| Change in Net Operating Assets | -- | -- | -48.84% | -50.10% | -- |
| Cash from Operations | -78.41% | -82.58% | 5.50% | 7.83% | -84.74% |
| Capital Expenditure | -14.29% | -9.09% | 145.45% | 145.45% | 72.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -14.29% | -9.09% | 145.45% | 145.45% | 72.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 28.02% | 28.02% | -11.11% | -11.11% | 1.43% |
| Issuance of Common Stock | 28.07% | 28.07% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -42.72% | -42.72% | -- | -- | -- |
| Cash from Financing | 27.48% | 30.46% | 192.41% | 189.86% | 26,022.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.32% | -9.25% | 7.09% | 9.39% | 336.34% |